Retatrutide RT10 10mg*10vials

Retatropeptide RT10 (10mg x 10 vials) is a high-purity, long-acting lyophilized research-grade peptide, hailed as a revolutionary three-target metabolic agonist. Unlike traditional single- or dual-target peptides, retatropeptide uniquely activates three core metabolic receptors: GLP-1, GIP, and glucagon receptor (GCGR), making it a state-of-the-art research peptide in metabolic physiology, obesity mechanisms, and glucose and lipid metabolism.

Product Function and Value

This triple synergistic peptide integrates three core metabolic regulatory pathways, providing comprehensive experimental effects unattainable by single-target peptides (such as semaglutide) and dual-target peptides (such as trepapin). The GLP-1 and GIP dual pathways effectively regulate insulin secretion, stabilize blood glucose levels, suppress appetite, and prolong satiety; while the newly added GCGR pathway significantly increases resting energy expenditure and accelerates lipid oxidation and browning of white adipose tissue. It is widely used in laboratory studies of metabolic disorder mechanisms, obesity intervention, glucose and lipid metabolism balance, and long-term metabolic remodeling, providing more comprehensive and in-depth data support for preclinical mechanism research.

Retatrutide RT10 10mg*10 vials, a high-purity lyophilized triple receptor agonist peptide. It activates GLP-1/GIP/GCGR for laboratory studies of higher metabolism, obesity, and glycolipid mechanisms. It exhibits long-lasting and stable activity, has obtained full COA certification, and is available for wholesale.